Goldman Sachs Group Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 14, 2024
SELL
$3.79 - $4.87 $64,376 - $82,721
-16,986 Reduced 58.13%
12,236 $51,000
Q1 2023

May 11, 2023
SELL
$3.79 - $4.87 $64,376 - $82,721
-16,986 Reduced 58.13%
12,236 $51,000
Q4 2022

May 14, 2024
BUY
$1.68 - $5.99 $49,092 - $175,039
29,222 New
29,222 $124,000
Q4 2022

Feb 13, 2023
BUY
$1.68 - $5.99 $49,092 - $175,039
29,222 New
29,222 $124,000

Others Institutions Holding RVPH

# of Institutions
40
Shares Held
9.97M
Call Options Held
133K
Put Options Held
43.9K
View Full List

About REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH Quotes by TradingView
  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $26M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email